Kiromic BioPharma Inc.

0.87
-0.13 (-13.00%)
At close: Jan 17, 2025, 3:20 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.04 -0.08 -0.68 -3.21 -11.9 -10.65
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio -0.1 -0.51 0.64 5.43 22.54 153.14
P/FCF Ratio -0.04 -0.1 -0.79 -8.14 -13.87 -17.74
P/OCF Ratio -0.04 -0.12 -0.86 -10.07 -15.31 -18.87
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -1.7 -1.63 0.02 0.04 n/a n/a
Quick Ratio 0.22 0.13 7.94 7.32 3.00 0.89
Current Ratio 0.22 0.13 7.94 7.32 3.03 0.92
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage 10.77 -186.87 -2.11K -5.82K -164.68 -5.03
Return on Equity (ROE) 2.33 6.61 -0.94 -1.69 -1.9 -14.38
Return on Assets (ROA) -1.75 -3.19 -0.83 -1.5 -1.41 -4.36
Return on Capital (ROIC) 2.43 23.65 -0.94 -1.69 -1.87 -12
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a